Who Owns Pulse Biosciences Stock?
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 15.41%
- Held by insiders
- 71.05%
- Institutional holders
- 169
- Institutions 15.4%
- Insiders 71.0%
- Public and other 13.5%
Who owns Pulse Biosciences stock?
Institutional investors own about 15.4% of Pulse Biosciences's shares, spread across 169 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 71.05% of PLSE.
The largest institutional holders are Blackrock Inc. (2.07%), Bank of America Corporation (2.04%) and Vanguard Capital Management LLC (1.11%). Together, the top 10 institutions control 11.4% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their PLSE positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PLSE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 1.47M | 2.07% | +9.5% |
| Bank of America Corporation | 1.45M | 2.04% | +67.0% |
| Vanguard Capital Management LLC | 788.64K | 1.11% | -3.3% |
| Portolan Capital Management, LLC | 753.33K | 1.06% | +2.7% |
| Price (T.Rowe) Associates Inc | 748.64K | 1.06% | +4938.3% |
| Balyasny Asset Management LP | 718.10K | 1.01% | +170.8% |
| Citadel Advisors Llc | 626.51K | 0.88% | +340.7% |
| Geode Capital Management, LLC | 536.28K | 0.76% | +9.0% |
| State Street Corporation | 529.62K | 0.75% | +15.9% |
| Massachusetts Financial Services Co. | 462.73K | 0.65% | -0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PLSE
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 554.61K | 0.78% |
| T. Rowe Price New Horizons Fund, Inc. | 485.30K | 0.69% |
| iShares Trust-iShares Russell 2000 ETF | 479.88K | 0.68% |
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 343.54K | 0.49% |
| MFS SERIES TRUST I-MFS New Discovery Fund | 339.45K | 0.48% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 215.88K | 0.30% |
| TR PRICE-Price (T.Rowe) New Horizons Trust | 214.40K | 0.30% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 210.12K | 0.30% |
| iShares Trust-iShares Russell 2000 Growth ETF | 175.60K | 0.25% |
| MFS VARIABLE INSURANCE TRUST-MFS New Discovery Series | 122.30K | 0.17% |
Frequently asked questions
Who is the largest shareholder of Pulse Biosciences?
Blackrock Inc. is the largest institutional shareholder of PLSE, owning 2.07% of shares outstanding (1.47M shares) as of its latest 13F filing.
What percentage of Pulse Biosciences is owned by institutions?
Institutions own about 15.4% of PLSE shares and 53.2% of the public float.
How much of Pulse Biosciences do insiders own?
Insiders, such as officers and directors, own about 71.05% of PLSE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.